{
  "abstract": "Daily aspirin almost halves the risk of colon and rectal cancer recurring in patients with a certain type of genetic alteration in the tumour, a Swedish study published in the New England Journal of Medicine has reported.1 Experts suggested that the findings will lead to a change in clinical practice for treating the condition.",
  "authors": [
    {
      "affiliations": [
        "The BMJ"
      ],
      "name": "Kate Bowie"
    }
  ],
  "title": "Low dose daily aspirin halves recurrence of colorectal cancer, study finds",
  "uid": "f69f9bec-901f-53a9-adc8-ae8516bec1c3"
}